ArticleAnatomia, histologia, embryologia2026
Determination of Expression and Relationships of Nedd4-Related E3 Ubiquitin Ligase-2 (NEDL2) and Ubiquitin Proteasome System Proteins in Developing Rat Pancreatic Tissue.
Article in Anatomia, histologia, embryologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nedd4-associated E3 ubiquitin ligase 2 (NEDL2) and p97/valosin-containing protein (p97/VCP) are critical regulators of ubiquitin-mediated proteostasis and cellular homeostasis. However, their age-dependent expression patterns in pancreatic tissue during postnatal development and senescent decline remain uncharacterized. This study aimed to investigate the histological alterations alongside the expression profiles of NEDL2 and p97/VCP in rat pancreatic tissue across the postnatal lifespan and ageing. Pancreatic tissues obtained from male Wistar albino rats at postnatal Weeks 1, 4, 10, 36 and 72 were evaluated using histochemical, immunohistochemical and immunofluorescence analyses. Haematoxylin and eosin (H&E) staining were performed to assess morphological changes in endocrine and exocrine pancreas. Immunohistochemistry and semi-quantitative H-score analyses were utilized to evaluate NEDL2 and p97/VCP expression levels. Double immunofluorescence staining was conducted to determine cellular co-localization of NEDL2 with p97/VCP, insulin and glucagon in pancreatic islet cells. Histological analysis showed that the islets of Langerhans progressively enlarged and hypertrophic changes during postnatal ageing, while the exocrine acinar structures maintained its morphological integrity. Immunohistochemical findings revealed dynamic and age-dependent expression of NEDL2 and p97/VCP. Both proteins demonstrated a progressive increase in expression from Week 1 through Week 4. NEDL2 expression peaked significantly at Week 10 (p < 0.001) followed by a gradual decline, whereas p97/VCP expression reached its maximum level at Week 36 (p < 0.001). A significant decrease in expression was observed at Week 72. Immunofluorescence analyses confirmed that NEDL2 strongly co-localized with p97/VCP, insulin-positive β cells and glucagon-positive α cells, particularly during young and mature adulthood (Weeks 10 and 36). Conversely, a marked reduction in fluorescence intensity and co-localization was observed in senescent pancreatic tissue (Week 72). These findings demonstrate that NEDL2 and p97/VCP exhibit coordinated and developmentally regulated expression patterns within pancreatic islet cells. Their elevated expression and prominent co-localization during adulthood suggest a key role for these proteins in pancreatic maturation, endocrine function and cellular proteostasis. Conversely, their down-regulation in senescent tissue may reflect an age-related impairment of protein quality control systems during pancreatic ageing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.